Clinical Trials Browser

Phase EARLY_PHASE1 × Surgical Procedures, Operative × 90 days × Clear all

NCT07144384 2026-02-13

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

Carcinoma, Basal Cell